Improved blood glucose variability, HBAlc Insuman Infusat and less insulin in IDDM patients using insulin lispro in CSII. The Swedish multicenter lispro insulin study (vol 26, pg 192, 2000)

被引：0

|

作者：

Johansson, UB

Adamson, UCK

Lins, PES

Wredling, RAM

机构：

来源：

DIABETES & METABOLISM | 2000年 / 26卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：423 / 423

页数：1

相关论文

共 4 条

[1] Improved blood glucose variability, HBA13 insuman infusat® and less insulin requirement in IDDM patients using insulin lispro in CSII.: The Swedish multicenter lispro insulin study
Johansson, UB
Adamson, UCK
Lins, PES
Wredling, RAM
[J]. DIABETES & METABOLISM, 2000, 26 (03) : 192 - 196
[2] Blood glucose variability and well-being during CSII using insulin lispro and regular insulin
Lins, PE
Johansson, UB
Wredling, R
Adamson, U
[J]. DIABETES, 1998, 47 : A10 - A10
[3] Combined therapy with insulin lispro mix 75/25 plus metformin or insulin glargine plus metformin: A 16-week, randomized, open-label, crossover study in patients with type 2 diabetes beginning insulin therapy (vol 26, pg 2034, 2004)
Malone, JK
[J]. CLINICAL THERAPEUTICS, 2005, 27 (07) : 1112 - 1112
[4] Comparison of blood glucose stability and HBA1c between implantable insulin pumps using U400 Hoe 21ph insulin and external pumps using lispro in type 1 diabetic patients:: A pilot study
Catargi, B
Meyer, L
Melki, V
Renard, E
Jeandidier, N
[J]. DIABETES & METABOLISM, 2002, 28 (02) : 133 - 137